|
Iranian Journal of Pharmacology and Therapeutics
Razi Institute for Drug Research (RIDR) of Iran University of Medical Sciences and Health Services (IUMS)
ISSN: 1735-2657
Vol. 5, No. 2, 2006, pp. 87-94
|
Bioline Code: pt06016
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Iranian Journal of Pharmacology and Therapeutics, Vol. 5, No. 2, 2006, pp. 87-94
en |
Review Article - Emerging Drug Therapies for Heart Failure
Balakumar, Pitchai & Singh, Manjeet
Abstract
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effective therapies for the management of this disease. The present review has discussed various potential therapeutic agents which may open new vistas for the management of heart failure.
Keywords
Heart failure, Candisartan, Spironolactone, Conivaptan, Nesiritide, Omapatrilat
|
|
© Copyright 2006 - Razi Institute for Drug Research (RIDR) Alternative site location: http://ijpt.iums.ac.ir/
|
|